Weighing the Risks of Perimyocarditis With the Benefits of SARS-CoV-2 mRNA Vaccination in Adolescents

J Pediatric Infect Dis Soc. 2021 Nov 11;10(10):937-939. doi: 10.1093/jpids/piab061.
No abstract available

MeSH terms

  • Adolescent
  • COVID-19*
  • Humans
  • RNA, Messenger
  • SARS-CoV-2*
  • Vaccination

Substances

  • RNA, Messenger